ATRC AtriCure, Inc. stock chart & analysis
Conviction 40HealthcareScan · Fri, Nov 6, 2026AtriCure, Inc. (ATRC) closed at $58.54 (-4.47%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 49, RS Rating 98, -11.4% from its 52-week high, +47.9% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.
Financials as of Wed, Sep 30, 2026 · quarterly.
ATRC technical analysis
Trend
ATRC is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 3.0% above the 50-day ($56.81) and 51.5% above the 200-day ($38.62). ADX(14) at 31 points to a strong, established trend. It meets 8 of 8 trend-template criteria.
Momentum
RSI(14) is 49, in the bearish half of its range. MACD crossed below its signal line on the latest session. Its RS Rating of 98 puts its weighted 12-month performance ahead of about 98% of the US market.
Volume and volatility
Volume on the latest session ran 1.0× its 20-day average. It trades about $47.5M a day on average. ATR(14) is $2.85, 4.9% of price — its typical daily range. Chaikin Money Flow (0.07) shows accumulation.
Key levels
The chart pattern's support is $51.82 and its resistance $64.51. The 52-week range is $25.36 to $66.02; price is 11.4% below the high and 130.7% above the low. The VWAP anchored at the 52-week high is $61.99, above price.
Performance
ATRC returned -4.5% (1 week), +10.7% (1 month), +40.5% (3 months), +122.6% (6 months), +81.0% (1 year), +47.9% (year to date).
About AtriCure, Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Surgical & Medical Instruments & Apparatus · Listed 2005 · 1,350 employees
Recent news
- AtriCure (ATRC) Q3 2026 Earnings Call TranscriptMotley Fool · Wed, Nov 4, 2026
Congress activity
Disclosed STOCK Act trades in ATRC · 4 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Gilbert Cisneros house · D · CA · traded 2026-09-29 | Sell | $1K–$15K | 2026-09-29 | 2026-10-12 | |
Gilbert Cisneros house · D · CA · traded 2026-08-20 | Buy | $1K–$15K | 2026-08-20 | 2026-09-10 | |
Gilbert Cisneros house · D · CA · traded 2025-05-06 | Buy | $1K–$15K | 2025-05-06 | 2025-06-06 | |
 Josh Gottheimer house · NJ · traded 2024-07-19 | Buy | $1K–$15K | 2024-07-19 | 2024-08-12 |
Insider activity
SEC Form 4 transactions in ATRC · open-market 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Privitera Salvatore Chief Technical Officer · Common Stock · 2026-11-04 | Sell | 8.4K | $546K | 2026-11-04 | 2026-11-05 |
GROVES REGINA E Director · Common Stock · 2026-09-11 | Sell | 5.31K | $288K | 2026-09-11 | 2026-09-14 |
Dahlquist Karl S. Chief Legal Officer · Common Stock · 2026-08-24 | Sell | 9.37K | $458K | 2026-08-24 | 2026-08-26 |
Prange Karen Director · Common Stock · 2026-08-05 | Sell | 3.56K | $138K | 2026-08-05 | 2026-08-07 |
Yuen Maggie Director · Common Stock · 2026-08-05 | Sell | 3.5K | $134K | 2026-08-05 | 2026-08-07 |
Prange Karen Director · Common Stock · 2026-05-20 | Sell | 3K | $86K | 2026-05-20 | 2026-05-22 |
WEHRWEIN SVEN Director · Common Stock · 2026-05-18 | Grant | 6.14K | $0 | 2026-05-18 | 2026-05-20 |
JOHNSON B KRISTINE Director · Common Stock · 2026-05-18 | Grant | 6.14K | $0 | 2026-05-18 | 2026-05-20 |
WHITE ROBERT S. Director · Common Stock · 2026-05-18 | Grant | 6.14K | $0 | 2026-05-18 | 2026-05-20 |
Prange Karen Director · Common Stock · 2026-05-18 | Grant | 6.14K | $0 | 2026-05-18 | 2026-05-20 |
SEC filings
EDGAR filings in ATRC · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.